Curanex Pharmaceuticals Inc Material Event - Nasdaq Compliance Update

If you follow Curanex Pharmaceuticals (ticker: CURX), you may have seen news about their status on the Nasdaq. Here is a plain-English breakdown of the situation and what it means for your portfolio.

1. What happened?

Nasdaq requires listed companies to maintain a share price of at least $1.00. Curanex did not meet this rule by the May 4, 2026, deadline. However, Nasdaq has granted the company an extra 180 days to regain compliance, moving their new deadline to November 2, 2026.

2. Why is this happening?

Think of the stock exchange like a club with a dress code. If a stock stays below $1.00 for 30 consecutive business days, the company receives a deficiency notice. Curanex has been in this position since November 2025. While they missed the price rule, they continue to meet all other Nasdaq listing requirements, which is why they were granted this extension.

3. Why does this matter?

If a company is delisted from the Nasdaq, its shares move to the "pink sheets" (Over-the-Counter markets). This can make it harder to buy or sell shares quickly, often leads to higher trading costs, and can negatively impact the company’s reputation or trigger issues with existing debt agreements. This extension is a "stay of execution" that gives Curanex more time to stabilize.

4. What is the company doing about it?

Curanex is actively working to regain compliance and has publicly stated they are considering a "reverse stock split."

• What is a reverse stock split? Imagine you have 10 small pizza slices. A reverse split combines them into one large slice. You still have the same amount of "pizza" (total value), but each individual slice is now worth more. Companies use this to artificially boost their share price to meet the $1.00 rule without changing the company's underlying value.

5. Who is affected?

• Investors: You may see increased price volatility as the market reacts to this uncertainty. This news confirms that the company is under significant pressure to improve its market appeal.
• The Company: Curanex must now either improve its financial performance to attract more buyers or proceed with the reverse split to keep its Nasdaq listing.

6. What happens next?

To remain on the Nasdaq, Curanex must keep its share price at or above $1.00 for at least 10 consecutive business days before November 2, 2026. If they fail to do so, they face potential delisting, though they would have the option to appeal the decision to a Nasdaq panel.

7. What should you do?

If you are currently invested or considering a position, keep these three things in mind:

• Watch the calendar: This is a long process, not an overnight fix.
• Understand the split: If a reverse split is announced, remember that it is a mechanical move to satisfy exchange rules, not a sign of improved business performance.
• Assess your risk tolerance: If you are uncomfortable with the uncertainty of a company fighting to stay on a major exchange, you might prefer to watch from the sidelines until the share price stabilizes.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and should not be taken as professional investment advice. Stock market investments carry risks; always do your own research or consult with a qualified professional before making financial decisions.